Methylene Blue IV Therapy: An Emerging Approach to Cognitive Wellness

May 8, 2026; By Benjamin Kosubevsky

Among the integrative therapies generating the most curiosity in Delray Beach, Aventura, and across South Florida is methylene blue—a compound with a 130-year medical history that is now being explored in the context of cognitive wellness and mitochondrial support. If you have encountered this therapy in your research and wondered what the actual science says, this post is for you.

What Is Methylene Blue?

Methylene blue is one of the oldest synthetic drugs in medicine, first synthesized in 1876 and used historically for malaria treatment, surgical staining, and as an antidote for methemoglobinemia (a blood disorder). It is FDA-approved for specific medical indications at defined doses. What has generated recent interest is research exploring its effects on mitochondrial function and neuroprotection at low doses.

The Mitochondrial Connection

At low concentrations, methylene blue functions as an alternative electron carrier in the mitochondrial electron transport chain. This means it can bypass damaged components of the chain and help maintain ATP (energy) production even when mitochondrial function is compromised. A comprehensive review published in Progress in Neurobiology described methylene blue’s neurometabolic mechanisms, including its ability to support mitochondrial respiration, reduce oxidative stress, and enhance memory consolidation in preclinical models (Rojas et al., Prog Neurobiol, 2012).

A randomized functional MRI study published in Radiology demonstrated measurable changes in brain activation patterns following low-dose methylene blue administration in healthy human subjects, including enhanced sustained attention and memory retrieval (Rodriguez et al., Radiology, 2017). This was among the first controlled human neuroimaging studies to document methylene blue’s effects on brain function in healthy individuals.

IV Delivery: The Rationale

While methylene blue is available orally, IV administration allows for precise dosing and higher bioavailability. Published research on methylene blue’s pharmacological properties has explored its potential relevance to neurodegenerative conditions, noting its ability to inhibit tau protein aggregation and reduce oxidative damage in neuronal tissue (Oz et al., Biochemical Pharmacology, 2011).

What to Expect at The Longevity Center FL

At The Longevity Center FL in West Palm Beach, methylene blue IV is administered at low doses under physician supervision by Dr. Kosubevsky. Prior to administration, patients undergo evaluation to rule out contraindications, including G6PD deficiency, serotonergic medication use, and other factors that may affect safety. Sessions are brief—typically under 60 minutes—and are integrated into a broader cognitive wellness or longevity plan.

Patients from Delray Beach can reach our clinic in approximately 20 minutes; residents of Aventura can access us in approximately 60 minutes via I-95.

Give Us a Call  +1 (561) 210-4033
Schedule a consultation at The Longevity Center FL in West Palm Beach. [Schedule an Appointment]

References

1. Rojas JC, Bruchey AK, Gonzalez-Lima F. Neurometabolic Mechanisms for Memory Enhancement and Neuroprotection of Methylene Blue. Progress in Neurobiology. 2012;96(1):32-45. [Full Text]
2. Rodriguez P, Zhou W, Barrett DW, et al. Multimodal Randomized Functional MR Imaging of the Effects of Methylene Blue in the Human Brain. Radiology. 2017;281(2):516-526. [Full Text]
3. Oz M, Lorke DE, Hasan M, Petroianu GA. Cellular and Molecular Actions of Methylene Blue in the Nervous System. Medicinal Research Reviews. 2011;31(1):93-117. [Full Text]